Evidence map›Paper›PMID 28694880›Full record

ArticleThe open biochemistry journal2017

Alzheimer's Disease and Paraoxonase 1 (

Mohsen Saeidi, Raheleh Shakeri, Abdoljalal Marjani, Safoura Khajeniazi

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The open biochemistry journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Paraoxonases at the Heart of Neurological Disorders.International journal of molecular sciences · 2023
    Review
  6. The Relationship between Cancer and Paraoxonase 1.Antioxidants (Basel, Switzerland) · 2022
    Review
  7. Review
  8. Paraoxonase Role in Human Neurodegenerative Diseases.Antioxidants (Basel, Switzerland) · 2020
    Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mohsen SaeidiStem Cell Research Center, Gorgan Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Golestan province, Iran.
Raheleh ShakeriStudent Research Committee, Gorgan Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Golestan province, Iran.
Abdoljalal MarjaniStudent Research Committee, Gorgan Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Golestan province, Iran.
Safoura KhajeniaziDepartment of Medical Technology, Faculty of Advanced Medical Sciences and Technology, Golestan University of Medical Sciences, Gorgan, Golestan province, Iran.
Golestan University · IRGolestan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSome studies have indicated that human paraoxonase 1 (

methodThe study included 100 healthy individuals and 50 patients. Enzyme activity and genetic polymorphism of

resultThere were significant differences in distribution of genotypes and alleles among patients and control group. The most common genotype was CT in patients and control group, while the most frequent alleles were T and C in patients and controls, respectively. There was a statistically significant variation between serum

conclusionOnset of Alzheimer's disease may depend on different polymorphisms of the

Indexed as

AlzheimerDiseaseGeneGorganPolymorphismPON1

Identifiers

PMID28694880
PMCPMC5481621
OpenAlexW2610602937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.